The Neuropathologic Substrates of Vascular-Ischemic Dementia

  • Kurt A. Jellinger
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Although Alzheimer’s disease (AD) has become widely accepted as the most common cause of dementia in advanced age (1), the role of cerebrovascular disease (CVD) and ischemic brain lesions in cognitive decline remains controversial and confusing (2, 3, 4, 5). Until the 1950 and 1960s, dementia in elderly subjects was usually labeled “atherosclerotic dementia,” although in 1919, Mingazzini (6) stated that this was the result of cerebral infarctions, similar to the concept stressed by Fisher (7). Tomlinson et al. (8) described the relationship between the volume of infarcted tissue and cognitive impairment, suggesting that destruction of large volumes of cortex may be necessarily followed by dementia, whereas subtle cerebrovascular lesions (CVLs) may or may not contribute to dementia, probably depending on their location. Hachinsky et al. (9) criticized the term “arteriosclerotic dementia” as both inaccurate and misleading and coined the term “multi-infarct dementia” (MID). Because MID constitutes only a small subdivision of all dementias of vascular etiology, the terms “vascular dementia” (VaD) (4,10, 11, 12, 13), “cerebrovascular dementia” (14), “dementia associated with stroke” (15), or, more recently, “ischemic-vascular dementia” (16,17) “vascular-ischemic dementia” or “vascular cognitive impairment” (ViD) (18) were chosen.

Keywords

Ischemia Codon Neuropathy Fibril Choline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jorm AF. Epidemiology: meta-analysis. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 85–97.Google Scholar
  2. 2.
    Garcia JH, Brown GG. Vascular dementia: neuropathologic alterations and metabolic brain changes. J Neurol Sci 1992;109:121–131.PubMedCrossRefGoogle Scholar
  3. 3.
    Munoz DG. The pathological basis of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5:77–90.PubMedCrossRefGoogle Scholar
  4. 4.
    Markesbery WR. Vascular dementia. In: Markesbery W, ed. Neuropathology of Dementing Disorders. London, UK: Arnold Publishers, 1998, pp. 293–311.Google Scholar
  5. 5.
    Mirra SS, Hyman BT. Vascular dementia. In: Graham D, Lantos P, eds. Greenfield’s Neuropathology. 7th Ed. London, UK: Arnold Publishing, 2002, pp. 241–245.Google Scholar
  6. 6.
    Mingazzini G. Anatomia clinica di centri nervosi. UTET, Torino 1913;548–573.Google Scholar
  7. 7.
    Fisher CM. Dementia in cerebral vascular disease. In: Toole J, Siekert R, Whisnant J, eds. Cerebral Vascular Disease. Sixth Princeton Conference. New York, NY: Greene and Stratton, 1968, pp. 232–236.Google Scholar
  8. 8.
    Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205–242.PubMedCrossRefGoogle Scholar
  9. 9.
    Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974;2:207–210.PubMedCrossRefGoogle Scholar
  10. 10.
    Mikol J. Vascular dementia. In: Duckett S, De la Torre JC, eds. Pathology of the Aging Human Nervous System, 2nd ed. New York, Oxford Univ. Press, 2001, pp. 101–122.Google Scholar
  11. 11.
    Esiri MM, Hyman BT, Beyreuther K, Masters CL. Vascular dementia. In: Graham D, Lantos P, eds. Greenfield’s Neuropathology. 6th Ed. London, UK: Arnold Publishing, 1997, pp. 204–210.Google Scholar
  12. 12.
    Leys D, Englund E, Erkinjuntti T. Vascular dementia. In: Qizilbash N, Schneider L, Brodaty H, Tariot P, Kaye J, Chui H, Erkinjuntti T, eds. Evidence Based Dementia Practice. Oxford, UK: Blackwell Science Publishing, 2002, pp. 260–287.Google Scholar
  13. 13.
    Markesbery WR. Overview of vascular dementia. In: Iqbal K, Sisodia S, Winblad B, eds. Alzheimer Disease: Advances in Etiology, Pathogenetics and Therapy. Paris, France: John Wiley & Sons, 2001, pp. 205–220.Google Scholar
  14. 14.
    Erkinjuntti T. Cerebrovascular dementia: pathophysiology, diagnosis and treatment. CNS Drugs 1999;12:35–18.CrossRefGoogle Scholar
  15. 15.
    Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke 1997;28:459–63.PubMedGoogle Scholar
  16. 16.
    Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931–945.PubMedGoogle Scholar
  17. 17.
    Jellinger KA. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 2002;203–204:153–157.PubMedCrossRefGoogle Scholar
  18. 18.
    Jellinger KA. Vascular-ischemic dementia: an update. J Neural Transm 2002;(Suppl):1–23.Google Scholar
  19. 19.
    Moncayo J, Bogousslavski J. Vascular dementia: persisting controversies and questions. Eur J Neurol 1996;3:299–308.Google Scholar
  20. 20.
    Bowler JV, Hachinski V. Current criteria for vascular dementia-a critical appraisal. In: Bowler JV, Hachinski V, eds. Vascular Cognitive Impairment: Preventable Dementia. Oxford, Oxford Univ. Press, 2003, pp. 1–11.Google Scholar
  21. 21.
    Arvanitakis Z, Hachinski V. Vascular cognitive impairment: what else do we need to learn? In: Terry R, Katzman R, Bick K, Sisodia S, eds. Alzheimer Disease. 2nd Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999, pp. 147–160.Google Scholar
  22. 22.
    Hyman BT. New neuropathological criteria for Alzheimer disease. Arch Neurol 1998;55:1174–1176.PubMedCrossRefGoogle Scholar
  23. 23.
    Jellinger KA. What is new in degenerative dementia disorders? Wien Klin Wochenschr 1999;111:682–704.PubMedGoogle Scholar
  24. 24.
    Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992;42:473–480.PubMedGoogle Scholar
  25. 25.
    Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.PubMedGoogle Scholar
  26. 26.
    Knopman DS, Parisi JE, Boeve BF, et al. Vascular dementia in a population-based autopsy study. Arch Neurol 2003;60:569–575.PubMedCrossRefGoogle Scholar
  27. 27.
    Goulding J, Signorini D, Chatterjee S, et al. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry 1999;67:654–657.PubMedGoogle Scholar
  28. 28.
    Jellinger KA. Inverse correlation between cerebrovascular lesions and Braak stage (letter). J Neurol Neurosurg Psychiatry 2000;68:799–800.PubMedCrossRefGoogle Scholar
  29. 29.
    Erkinjuntti T. Classification and criteria. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 99–113.Google Scholar
  30. 30.
    Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037–1044.PubMedGoogle Scholar
  31. 31.
    Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990;95:239–258.PubMedCrossRefGoogle Scholar
  32. 32.
    Ulrich J, Probst A, Wuest M. The brain diseases causing senile dementia. A morphological study on 54 consecutive autopsy cases. J Neurol 1986;233:118–122.PubMedCrossRefGoogle Scholar
  33. 33.
    Olsson Y, Brun A, Englund E. Fundamental pathological lesions in vascular dementia. Acta Neurol Scand Suppl 1996;168:31–38.PubMedGoogle Scholar
  34. 34.
    Pohjasvaara T, Mantyla R, Salonen O, et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000;57:1295–1300.PubMedCrossRefGoogle Scholar
  35. 35.
    Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 1994;51:888–895.PubMedGoogle Scholar
  36. 36.
    Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995;152:1476–1484.PubMedGoogle Scholar
  37. 37.
    Moroney JT, Bagiella E, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997;49:1096–1105.PubMedGoogle Scholar
  38. 38.
    Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30–36.PubMedGoogle Scholar
  39. 39.
    Gertz HJ, Wolf H, Arendt T. [Vascular dementia]. Nervenarzt 2002;73:393–404.PubMedCrossRefGoogle Scholar
  40. 40.
    Bowler JV, Munoz DG, Merskey H, Hachinski V. Fallacies in the pathological confirmation of the diagnosis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1998;64:18–24.PubMedGoogle Scholar
  41. 41.
    Chui HC, Mack W, Jackson JE, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 2000;57:191–196.PubMedCrossRefGoogle Scholar
  42. 42.
    Gold G, Giannakopoulos P, Montes-Paixao Junior C, et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690–694.PubMedGoogle Scholar
  43. 43.
    O’Brien MD. How does cerebrovascular disease cause dementia. Dementia 1994;5:133–136.PubMedCrossRefGoogle Scholar
  44. 44.
    Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 2000;59(Suppl):23–30.Google Scholar
  45. 45.
    Gustafson I, Passant U. Clinical pathological correlates. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 85–97.Google Scholar
  46. 46.
    Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143–1153.PubMedGoogle Scholar
  47. 47.
    Englund E. White matter pathology in vascular dementia. In: Chiu E, Gustafson L, Ames D, Folstein M, eds. Cerebrovascular Disease and Dementia. Pathology, Neuropsychiatry and Management. London, UK: Martin Dunitz Publishers, 2000, pp. 77–84.Google Scholar
  48. 48.
    Englund E. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 2002;13(Suppl):11–15.PubMedCrossRefGoogle Scholar
  49. 49.
    Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci 2000;903:239–243.PubMedCrossRefGoogle Scholar
  50. 50.
    Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H. Neuropathologic correlates of leuko-arabinosis. Arch Neurol 1989;46:1124–1128.PubMedGoogle Scholar
  51. 51.
    Pantoni L, Palumbo V, Sarti C. Pathological lesions in vascular dementia. Ann N Y Acad Sci 2002;977:279–291.PubMedGoogle Scholar
  52. 52.
    Rocca WA, Hofman A, Brayne C, et al. The prevalence of vascular dementia in Europe: facts and fragments from 1980–1990 studies. EURODEM-Prevalence Research Group. Ann Neurol 1991;30:817–824.PubMedCrossRefGoogle Scholar
  53. 53.
    Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991;41:1886–1892.PubMedGoogle Scholar
  54. 54.
    Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995;14:240–257.PubMedCrossRefGoogle Scholar
  55. 55.
    Meyer JS, Rauch GM, Lechner H, Loeb C. Vascular Dementia. Armonk, NY: Futura Publishing, 2001, pp. 320.Google Scholar
  56. 56.
    Reed BR. Vascular dementia. Arch Neurol 2004;61:433–435.PubMedCrossRefGoogle Scholar
  57. 57.
    Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002;203-204:7–10.PubMedCrossRefGoogle Scholar
  58. 58.
    Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 2003;74:720–724.PubMedCrossRefGoogle Scholar
  59. 59.
    Kase CS. Epidemiology of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5:71–76.PubMedCrossRefGoogle Scholar
  60. 60.
    Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S4–S9.PubMedGoogle Scholar
  61. 61.
    Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000;54:447–151.PubMedGoogle Scholar
  62. 62.
    Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 2000;31:1487–1493.PubMedGoogle Scholar
  63. 63.
    Hasegawa K, Homma A, Imai Y. An epidemiological study of age-related dementia in the community. Int J Geriatr Psychiatry 1986;l:94–105.Google Scholar
  64. 64.
    Li G, Shen YC, Chen CH, Zhau YW, Li SR, Lu M. A three-year follow-up study of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 1991;83:99–104.PubMedCrossRefGoogle Scholar
  65. 65.
    Ueda K, Kawano H, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992;23:798–803.PubMedGoogle Scholar
  66. 66.
    Yoshitake T, KiyO’Hara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161–1168.PubMedGoogle Scholar
  67. 67.
    Ikeda M, Hokoishi K, Maki N, et al. Increased prevalence of vascular dementia in Japan: a community-based epide-miological study. Neurology 2001;57:839–844.PubMedGoogle Scholar
  68. 68.
    Chiu HF, Lam LC, Chi I, et al. Prevalence of dementia in Chinese elderly in Hong Kong. Neurology 1998;50:1002–1009.PubMedGoogle Scholar
  69. 69.
    Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749–753.PubMedGoogle Scholar
  70. 70.
    Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215–1222.PubMedCrossRefGoogle Scholar
  71. 71.
    Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Incidence of vascular dementia in Rochester, MN, 1985–1989. Arch Neurol 2002;59:1605–1610.PubMedCrossRefGoogle Scholar
  72. 72.
    Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003;60:1082–1088.PubMedCrossRefGoogle Scholar
  73. 73.
    Hulette C, Nochlin D, McKeel D, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997;48:668–672.PubMedGoogle Scholar
  74. 74.
    Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153–158.PubMedCrossRefGoogle Scholar
  75. 75.
    Desmond DW, Moroney JT, Sano M, Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002;33:2254–2260.PubMedCrossRefGoogle Scholar
  76. 76.
    Mirsen T, Hachinski V. The epidemiology and classification of vascular and multi-infarct dementia. In: Meyer J, Lechner H, Marshall J, Toole J, eds. Vascular and Multi-infarct Dementia. Mount Kisco, NY: Futura Publishing, 1988, pp. 61–76.Google Scholar
  77. 77.
    Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol 2000;57:713–719.PubMedCrossRefGoogle Scholar
  78. 78.
    Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813–817.PubMedCrossRefGoogle Scholar
  79. 79.
    Corsellis JAN. Mental Illness and the Ageing Brain. London, UK: University Press, 1962.Google Scholar
  80. 80.
    Birkett DP. The psychiatric differentiation of senility and arteriosclerosis. Br J Psychiatry 1972;120:321–325.PubMedGoogle Scholar
  81. 81.
    Todorov AB, Go RC, Constantinidis J, Elston RC. Specificity of the clinical diagnosis of dementia. J Neurol Sci 1975;26:81–98.PubMedCrossRefGoogle Scholar
  82. 82.
    Sourander P, Walinder J. Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol (Berl) 1977;39:247–254.CrossRefGoogle Scholar
  83. 83.
    de Reuck J, Sieben G, de Coster W, vander Eecken H. Dementia and confusional state in patients with cerebral infarcts. A clinicopathological study. Eur Neurol 1982;21:94–97.PubMedGoogle Scholar
  84. 84.
    Mölsä PK, Paljarvi L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085–1090.PubMedGoogle Scholar
  85. 85.
    Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 1987;74:209–225.CrossRefGoogle Scholar
  86. 86.
    Wade JP, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987;44:24–29.PubMedGoogle Scholar
  87. 87.
    Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer’s disease: autopsy results in 150 cases. Ann Neurol 1988;24:50–56.PubMedCrossRefGoogle Scholar
  88. 88.
    Boiler F, Lopez OL, Moossy J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989;39:76–79.Google Scholar
  89. 89.
    del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia. A clinicopathological study. J Neurol Sci 1990;96:1–17.PubMedCrossRefGoogle Scholar
  90. 90.
    Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994;5:145–147.PubMedCrossRefGoogle Scholar
  91. 91.
    Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer’s disease, Lewy body disease, vascular lesions. Dementia 1995;6:162–168.PubMedCrossRefGoogle Scholar
  92. 92.
    Bowler JV, Eliasziw M, Steenhuis R, et al. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol 1997;54:697–703.PubMedGoogle Scholar
  93. 93.
    Snowdon DA, Markesbery WR. The prevalence of neuropathologically confirmed vascular dementia: findings from the Nun study 1st Intern Congr on Vascular Dementia, Geneva, Switzerland, October 1999. Bologna, Italy: Monduzzi Editore S.p.A, 1999, pp. 19–24.Google Scholar
  94. 94.
    Nolan KA, Lino MM, Seligmann AW, Blass JP. Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 1998;46:597–604.PubMedGoogle Scholar
  95. 95.
    Seno H, Ishino H, Inagaki T, Iijima M, Kaku K, Inata T. A neuropathological study of dementia in nursing homes over a 17-year period, in Shimane Prefecture, Japan. Gerontology 1999;45:44–48.PubMedCrossRefGoogle Scholar
  96. 96.
    Akatsu H, Takahashi M, Matsukawa N, et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 2002;196:63–69.PubMedCrossRefGoogle Scholar
  97. 97.
    Neuropathology G. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169–175.CrossRefGoogle Scholar
  98. 98.
    Jellinger K, Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimer disease. A comparative autopsy study. J Neurol 2003;250:1050–1055.PubMedCrossRefGoogle Scholar
  99. 99.
    Loeb C. Neuropathological correlates of vascular dementia. In: Meyer J, Rauch G, Lechner H, Loeb C, Toole J, eds. Vascular Dementia. Armonk, NY: Futura Publishing, 2001, pp. 59–75.Google Scholar
  100. 100.
    Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138–143.PubMedGoogle Scholar
  101. 101.
    De Reuck J, De Reus R, De Koninck J. Sneddon’s syndrome. A not unusual cause of stroke in young women. In: Meyer J, Lechner H, Reivich M, Ott E, eds. Cerebral Vascular Disease. Amsterdam, The Netherlands: Excerpta Medica 6, 1987, pp. 171–174.Google Scholar
  102. 102.
    Marie P. Des foyers lacunaires de disintegration et de differents autres etats cavitaires du cerveau. Rev Med 1901;21:281–3298.Google Scholar
  103. 103.
    Fisher CM. Lacunes: small, deep cerebral infarcts. 1965. Neurology 1998;50:841–852.PubMedGoogle Scholar
  104. 104.
    Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982;32:871–876.PubMedGoogle Scholar
  105. 105.
    Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawa J. Ischemic stroke and incomplete infarction. Stroke 1995;27:761–765.Google Scholar
  106. 106.
    Poirier J, Derouesne C. Cerebral lacunae. A proposed new classification. Clin Neuropathol 1984;3:266.PubMedGoogle Scholar
  107. 107.
    Poirier J, Derouesne C. [The concept of cerebral lacunae from 1838 to the present]. Rev Neurol (Paris) 1985;141:3–17.Google Scholar
  108. 108.
    Tuszynski MH, Petito CK, Levy DE. Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke 1989:20:990–999.PubMedGoogle Scholar
  109. 109.
    Lassen NA. Incomplete cerebral infarction-focal incomplete ischemic tissue necrosis not leading to emollision. Stroke 1982;13:522–523.PubMedGoogle Scholar
  110. 110.
    Ma CK, Olsson Y. The role of chronic brain edema in the formation of lacunes in Binswanger’s encephalopathy. Histopathology and immunohistochemical observations. Cerebrovasc Dis 1997;7:324–331.CrossRefGoogle Scholar
  111. 111.
    Lammie GA. Pathology of lacunar infarction. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcorti-cal Stroke. Oxford, UK: Oxford University Press, 2002, pp. 38–6.Google Scholar
  112. 112.
    Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002;12:358–370.PubMedGoogle Scholar
  113. 113.
    Derouesne C, Gray F, Escourelle R, Castaigne P. ‘Expanding cerebral lacunae’ in a hypertensive patient with normal pressure hydrocephalus. Neuropathol Appl Neurobiol 1987;13:309–320.PubMedGoogle Scholar
  114. 114.
    Pollock H, Hutchings M, Weller RO, Zhang ET. Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes. J Anat 1997;191:337–346.PubMedCrossRefGoogle Scholar
  115. 115.
    Hughes W. Hypothesis—origin of lacunes. Lancet 1965;2:19–21.CrossRefGoogle Scholar
  116. 116.
    Roman GC. Lagunas cerebrales. Estudio clínico y neurópatôlogico de 100 cases fatales. Rev Facultad Ciencias Medicas/Univ Nac Córdoba 1981;39:115–129.Google Scholar
  117. 117.
    De Reuck J, Van der Eecken H. The topography of infarcts in the lacunar state. In: Meyer J, Lechner H, Reivich M, eds. Cerebral Vascular Disease 7. Stuttgart, Germany: Thieme, 1976, pp. 162–165.Google Scholar
  118. 118.
    Pullicino PM. Pathogenesis of lacunar infarcts and small deep infarcts. Adv Neurol 1993;62:125–140.PubMedGoogle Scholar
  119. 119.
    Leys D, Bogousslavsky J. Mechanisms of vascular dementia. In: Leys D, Scheltens P, eds. Current Issues in Neurodegenerative Diseases. Vol. 6: Vascular Dementia. Amsterdam, The Netherlands: ICG, 1994, pp. 121–132.Google Scholar
  120. 120.
    Benson DF, Cummings JL. Angular gyrus syndrome simulating Alzheimer’s disease. Arch Neurol 1982;39:616–620.PubMedGoogle Scholar
  121. 121.
    Zekry D, Duyckaerts C, Belmin J, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging 2003;24:213–219.PubMedCrossRefGoogle Scholar
  122. 122.
    Castaigne P, Lhermitte F, Buge A, Escourolle R, Hauw JJ, Lyon-Caen O. Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol 1981;10:127–148.PubMedCrossRefGoogle Scholar
  123. 123.
    de Freitas GR, Bogousslavsky J. Thalamic infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. 2nd Ed. Oxford, UK: Oxford University Press, 2002, pp. 255–285.Google Scholar
  124. 124.
    Szirmai I, Vastagh I, Szombathelyi E, Kamondi A. Strategic infarcts of the thalamus in vascular dementia. J Neurol Sci 2002;203—204:91–97.PubMedCrossRefGoogle Scholar
  125. 125.
    Brion S, Pragier G, Guerin R, Teitgen M. Syndrome de Korsakoff par ramollissement bilateral du fornix. Rev Neurol 1969;120:255–262.PubMedGoogle Scholar
  126. 126.
    Escourolle R, Gray F. Les accidents vasculaires du systeme limbique 7th Congr Neuropathol Budapest. Amsterdam, The Netherlands: Excerpta Medica, 1975.Google Scholar
  127. 127.
    Glees P, Griffith GH. Bilateral destruction of the hippocampus in case of dementia. Monatsschr Psych Neurol 1953;123:193–204.Google Scholar
  128. 128.
    Caplan LR. Binswanger’s disease—revisited. Neurology 1995;45:626–633.PubMedGoogle Scholar
  129. 129.
    Caplan LR, Helgason CM. Caudate infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Lacunar and Other Subcortical Infarctions. Oxford, UK: Oxford University Press, 1995, pp. 117–130.Google Scholar
  130. 130.
    de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145–151.PubMedCrossRefGoogle Scholar
  131. 131.
    de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765–772.PubMedCrossRefGoogle Scholar
  132. 132.
    Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm Suppl 1998;53:31–39.PubMedGoogle Scholar
  133. 133.
    Hentschel F, Kreis M, Damian M, Krumm B. [Microangiopathic lesions of white matter. Quantitation of cerebral MRI findings and correlation with psychological tests], Nervenarzt 2003;74:355–361.PubMedCrossRefGoogle Scholar
  134. 134.
    Ward NS, Brown MM. Leukoariosis. In: Cummings JL, ed. Subcortical Dementia. Oxford, UK: Oxford University Press, 1990, pp. 47–68.Google Scholar
  135. 135.
    Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berliner Klin Wochenschr 1894;31:1103–1105, 1137–1139, 1180–1186.Google Scholar
  136. 136.
    Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21–23.PubMedGoogle Scholar
  137. 137.
    Babikian V, Ropper AH. Binswanger’s disease: a review. Stroke 1987;18:2–12.PubMedGoogle Scholar
  138. 138.
    Blass JP, Hoyer S, Nitsch R. A translation of Otto Binswanger’s article, ‘The delineation of the generalized progressive paralyses’. 1894. Arch Neurol 1991;48:961–972.PubMedGoogle Scholar
  139. 139.
    Brun A, Fredriksson K, Gustafson L. Pure subcortical arteriosclerotic encephalopathy (Binswanger’s disease): a clini-copathological study. Part I: pathological features. Cerebrovasc Dis 1992;2:87–92.CrossRefGoogle Scholar
  140. 140.
    Fisher CM. Binswanger’s encephalopathy: a review. J Neurol 1989;236:65–79.PubMedCrossRefGoogle Scholar
  141. 141.
    Jellinger K, Neumayer E. Progressive subcortical Encephalopathie Binswanger. Eine klinisch-neuropathologische Studie. Arch Psych Z Ges Neurologie 1964;205:523–554.CrossRefGoogle Scholar
  142. 142.
    Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke 1995;26:1293–1301.PubMedGoogle Scholar
  143. 143.
    Van de Nes JAP, Zimmer R, Janzen RWC, Turowski B, Hurtle E, Schlote W. Mini-infarct encephalopathy associated with uncommon microvessel convolute formation presenting with presenile dementia. Clin Neuropathol 2003;22:101–109.PubMedGoogle Scholar
  144. 144.
    Grafton ST, Sumi SM, Stimac GK, Alvord EC, Jr., Shaw CM, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol 1991;48:293–298.PubMedGoogle Scholar
  145. 145.
    van Swieten JC, Geyskes GG, Derix MM, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991;30:825–830.PubMedCrossRefGoogle Scholar
  146. 146.
    Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13:7–10.PubMedCrossRefGoogle Scholar
  147. 147.
    Wakita H, Tomimoto H, Akiguchi I, et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 2002;924:63–70.PubMedCrossRefGoogle Scholar
  148. 148.
    Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoariosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1990;11:273–281.PubMedGoogle Scholar
  149. 149.
    Brown MM, Pelz DM, Hachinski VC. White matter vasodilatory reserve is impaired in patients with cerebrovascular disease and diffuse periventricular lacunes. J Neurol 1990;237:157.Google Scholar
  150. 150.
    Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25:375–381.PubMedGoogle Scholar
  151. 151.
    Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol 1995;52:773–780.PubMedGoogle Scholar
  152. 152.
    Kwan LT, Reed BR, Eberling JL, et al. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol 1999;56:809–814.PubMedCrossRefGoogle Scholar
  153. 153.
    Yoshikawa T, Murase K, Oku N, et al. Quantification of the heterogeneity of cerebral blood flow in vascular dementia. J Neurol 2003;250:194–200.PubMedCrossRefGoogle Scholar
  154. 154.
    Yoshikawa T, Murase K, Oku N, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessel disease. J Nucl Med 2003;44:505–511.PubMedGoogle Scholar
  155. 155.
    DeReuck J, Schaumburg HH. Periventricular atherosclerotic leukoencephalopathy. Neurology 1972;22:1094–1097.PubMedGoogle Scholar
  156. 156.
    Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol 1990;11:431–439.PubMedGoogle Scholar
  157. 157.
    Mayer PL, Kier EL. The controversy of the periventricular white matter circulation: a review of the anatomic literature. AJNR Am J Neuroradiol 1991;12:223–228.PubMedGoogle Scholar
  158. 158.
    Feigin L, Poport N. Neuropathological changes late in cerebral edema. The relationship to trauma, hypertensive disease and Binswanger’s encephalopathy. J Neuropathol Exp Neurol 1963;22:500–511.PubMedGoogle Scholar
  159. 159.
    Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Radiology 1987;162:509–511.PubMedGoogle Scholar
  160. 160.
    Salahuddin TS, Johansson BB, Kalimo H, Olsson Y. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study. Neuropathol Appl Neurobiol 1988;14:467–482.PubMedGoogle Scholar
  161. 161.
    De Reuck J. Neuropathology of vascular dementia. In: Leys D, Scheltens P, eds. Current Issues in Neurodegenerative Diseases. Vol. 6: Amsterdam, The Netherlands: Vascular Dementia. ICG, 1994, pp. 9–15.Google Scholar
  162. 162.
    Chabriat H, Bousser MG. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. 2nd Ed. Oxford, UK: Oxford University Press, 2002, pp. 116–126.Google Scholar
  163. 163.
    Filley CM, Thompson LL, Sze CI, Simon JA, Paskavitz JF, Kleinschmidt-DeMasters BK. White matter dementia in CADASIL. J Neurol Sci 1999;163:163–167.PubMedCrossRefGoogle Scholar
  164. 164.
    Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 2002;12:371–384.PubMedCrossRefGoogle Scholar
  165. 165.
    Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985;18:54–59.PubMedCrossRefGoogle Scholar
  166. 166.
    Tomimoto H, Akiguchi I, Akiyama H, et al. Vascular changes in white matter lesions of Alzheimer’s disease. Acta Neuropathol (Berl) 1999;97:629–634.CrossRefGoogle Scholar
  167. 167.
    Waxman SG. Molecular mechanisms of subcortical versus cortical infarction. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. Oxford, UK: Oxford University Press, 2002, pp. 67–83.Google Scholar
  168. 167a.
    Brown WR, Moody DM, Thore CR, Challa VR. Apoptosis in leukoaraiosis. AJNR Am J Neuroradiol 2000;21:79–82.PubMedGoogle Scholar
  169. 168.
    Hanyu H, Tanaka Y, Shimizu S, et al. Cerebral microbleeds in Binswanger’s disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett 2003;340:213–216.PubMedCrossRefGoogle Scholar
  170. 169.
    Loeb C. Binswanger’s disease is not a single entity. Neurol Sci 2000;21:343–348.PubMedCrossRefGoogle Scholar
  171. 170.
    Tanoi Y, Okeda R, Budka H. Binswanger’s encephalopathy: serial sections and morphometry of the cerebral arteries. Acta Neuropathol (Berl) 2000;100:347–355.CrossRefGoogle Scholar
  172. 171.
    Tomimoto H, Akiguchi I, Wakita H, Kimura J. [Changes in glial cells in Binswanger-type infarction]. No To Shinkei 1994;46:771–779.PubMedGoogle Scholar
  173. 172.
    Zhang WW, Badonic T, Hoog A, et al. Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: a review. Immunohistochemical studies on expression of col-lagens, basal lamina components and endothelin-1. Dementia 1994;5:153–162.PubMedCrossRefGoogle Scholar
  174. 173.
    Yamanouchi H. Loss of white matter oligodendrocytes and astrocytes in progressive subcortical vascular encephalopathy of Binswanger type. Acta Neurol Scand 1991;83:301–305.PubMedGoogle Scholar
  175. 174.
    Zambenedetti P, Schmitt HP, Zatta P. Metallothionein I-II immunocytochemical reactivity in Binswanger’s encephalopathy. J Alzheimers Dis 2002;4:459–466.PubMedGoogle Scholar
  176. 175.
    Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217–220.PubMedCrossRefGoogle Scholar
  177. 176.
    Zhan SS, Beyreuther K, Schmitt HP. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia 1994;5:79–87.PubMedCrossRefGoogle Scholar
  178. 177.
    Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626–1635.PubMedGoogle Scholar
  179. 178.
    Mungas D, Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 2001;57:2229–2235.PubMedGoogle Scholar
  180. 179.
    Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979;36:65–73.PubMedGoogle Scholar
  181. 180.
    Wardlaw JM, Dennis MS, Warlow CP, Sandercock PA. Imaging appearance of the symptomatic perforating artery in patients with lacunar infarction: occlusion or other vascular pathology? Ann Neurol 2001;50:208–215.PubMedCrossRefGoogle Scholar
  182. 181.
    Van der Eecken H. Anastomoses between the leptomeningeal arteries of the brain. Springfield, IL: Charles C. Thomas, 1959.Google Scholar
  183. 182.
    Paulson GW, Kapp J, Cook W. Dementia associated with bilateral carotid artery disease. Geriatrics 1966;21:159–166.PubMedGoogle Scholar
  184. 183.
    Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke 1984;15:221–223.PubMedGoogle Scholar
  185. 184.
    Dickson DW. Neuropathology of Alzheimer’s disease and other dementias. Clin Geriatr Med 2001;17:209–228.PubMedCrossRefGoogle Scholar
  186. 185.
    Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (>or = 80 years of age) humans. Acta Neuropathol (Berl) 1994;88:212–221.CrossRefGoogle Scholar
  187. 186.
    Jellinger KA. Hippocampal sclerosis: a common pathological feature of dementia in very old humans. Acta Neuropathol (Berl) 1994;88:599.CrossRefGoogle Scholar
  188. 187.
    Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Severity of vascular dementia is related to volume of metaboli-cally impaired tissue. Arch Neurol 1992;49:909–913.PubMedGoogle Scholar
  189. 188.
    Erkinjuntti T, Benavente O, Eliasziw M, et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 1996;53:325–332.PubMedGoogle Scholar
  190. 189.
    Basso A, Capitani E, Luzzatti C, Spinnler H. Intelligence and left hemisphere disease. The role of aphasia, apraxia and size of lesion. Brain 1981;104:721–734.PubMedCrossRefGoogle Scholar
  191. 190.
    Cummings JL, Benson DF. Psychological dysfunction accompanying subcortical dementias. Annu Rev Med 1988;39:53–61.PubMedCrossRefGoogle Scholar
  192. 191.
    Tatemichi TK, Sacktor N, Mayeux R. Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terr RD, Katzman R, Bick KL, eds. Alzheimer’s Disease. New York, NY: Raven Press, 1994, pp. 123–166.Google Scholar
  193. 192.
    Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859–876.PubMedCrossRefGoogle Scholar
  194. 193.
    Caplan LR. Caudate infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical Stroke. 2nd Ed. Oxford, UK: Oxford University Press, 2002, pp. 208–223.Google Scholar
  195. 194.
    Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittelforschung 1995;45:371–385.PubMedGoogle Scholar
  196. 195.
    Tatemichi TK, Desmond DW, Prohovnik I, et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992;42:1966–1979.PubMedGoogle Scholar
  197. 196.
    Du AT, Schuff N, Laakso MP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002;58:1635–1641.PubMedGoogle Scholar
  198. 197.
    Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 2002;72:747–751.PubMedCrossRefGoogle Scholar
  199. 198.
    Cordoliani-Mackowiak MA, Henon H, Pruvo JP, Pasquier F, Leys D. Poststroke dementia: influence of hippocampal atrophy. Arch Neurol 2003;60:585–590.PubMedCrossRefGoogle Scholar
  200. 199.
    Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479–486.PubMedGoogle Scholar
  201. 200.
    McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia withLewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124.PubMedGoogle Scholar
  202. 201.
    Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413–126.PubMedGoogle Scholar
  203. 202.
    Fearnley JM, Lees AJ. Pathology of Parkinson disease. In: Calne D, ed. Neurodegenerative Diseases. Philadelphia, PA: WB Saunders, 1994, pp. 545–554.Google Scholar
  204. 203.
    Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003;62:885–898.PubMedGoogle Scholar
  205. 204.
    Vinters HV, Farag ES. Amyloidosis of cerebral arteries. In: Barnett HJM, Bogousslavsky J, Meldrum H, eds. Ischemic Stroke: Advances in Neurology, Vol. 92. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, pp. 105–120.Google Scholar
  206. 205.
    Thai DR, Ghebremedhin E, Rub U, Yamaguchi H, Tredici KD, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2002;61:282–293.Google Scholar
  207. 206.
    Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E e2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998;50:961–965.PubMedGoogle Scholar
  208. 207.
    Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993;116:135–141.PubMedCrossRefGoogle Scholar
  209. 208.
    Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002;109:813–836.PubMedCrossRefGoogle Scholar
  210. 209.
    Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988;19:205–210.PubMedGoogle Scholar
  211. 210.
    Scholz W. Studien zur Pathologie der Hirngefasse II: Die drusige Entartung der Hirnarterien und Capillaren. Z Ges Neurol Psychiat 1938;162:694–715.Google Scholar
  212. 211.
    Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 1981;29:151–157.PubMedGoogle Scholar
  213. 212.
    Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983;14:924–928.PubMedGoogle Scholar
  214. 213.
    Yoshimura M, Yamanouchi H, Kuzuhara S, et al. Dementia in cerebral amyloid angiopathy: a clinicopathological study. J Neurol 1992;239:441–450.PubMedCrossRefGoogle Scholar
  215. 214.
    Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987;234:371–376.PubMedCrossRefGoogle Scholar
  216. 215.
    Bergeron C, Ranalli PJ, Miceli PN. Amyloid angiopathy in Alzheimer’s disease. Can J Neurol Sci 1987;14:564–569.PubMedGoogle Scholar
  217. 216.
    Ellis RJ, Olichney JM, Thai LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 1996;46:1592–1596.PubMedGoogle Scholar
  218. 217.
    Esiri MM, Wilcock GK. Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 1986;49:1221–1226.PubMedGoogle Scholar
  219. 218.
    Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP, Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991;30:637–649.PubMedCrossRefGoogle Scholar
  220. 219.
    Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S115–S123.PubMedCrossRefGoogle Scholar
  221. 220.
    Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog Neurobiol 2001;64:575–611.PubMedCrossRefGoogle Scholar
  222. 221.
    Olichney JM, Ellis RJ, Katzman R, Sabbagh MN, Hansen L. Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer’s disease. Ann N Y Acad Sci 1997;826:493–497.PubMedCrossRefGoogle Scholar
  223. 222.
    Kalaria RN. The role of cerebral ischemia in Alzheimer’s disease. Neurobiol Aging 2000;21:321–330.PubMedCrossRefGoogle Scholar
  224. 223.
    Lee SS, Stemmermann GN. Congophilic angiopathy and cerebral hemorrhage. Arch Pathol Lab Med 1978;102:317–321.PubMedGoogle Scholar
  225. 224.
    Ishii N, Nishihara Y, Horie A. Amyloid angiopathy and lobar cerebral haemorrhage. J Neurol Neurosurg Psychiatry 1984;47:1203–1210.PubMedGoogle Scholar
  226. 225.
    Feldmann E, Tornabene J. Diagnosis and treatment of cerebral amyloid angiopathy. Clin Geriatr Med 1991;7:617–630.PubMedGoogle Scholar
  227. 226.
    Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000;31:123–127.PubMedGoogle Scholar
  228. 227.
    Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thai LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E epsilon4. Arch Neurol 2000;57:869–874.PubMedCrossRefGoogle Scholar
  229. 228.
    Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000;59:768–773.PubMedGoogle Scholar
  230. 229.
    Tabaton M, Caponnetto C, Mancardi G, Loeb C. Amyloid beta protein deposition in brains from elderly subjects with leukoariosis. J Neurol Sci 1991;106:123–127.PubMedCrossRefGoogle Scholar
  231. 230.
    Wattendorff AR, Frangione B, Luyendijk W, Bots GT. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J Neurol Neurosurg Psychiatry 1995;58:699–705.PubMedGoogle Scholar
  232. 231.
    Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697–705.PubMedCrossRefGoogle Scholar
  233. 232.
    Abrahamson M, Jonsdottir S, Olafsson I, Jensson O, Grubb A. Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 1992;89:377–380.PubMedCrossRefGoogle Scholar
  234. 233.
    Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992;1:218–221.PubMedCrossRefGoogle Scholar
  235. 234.
    Tagliavini F, Rossi G, Padovani A, et al. A new pPP mutationrelated to hereditary cerebral hemorrhage. Alz Reports 1999;2:S28.Google Scholar
  236. 235.
    Nilsberth C, Westlind-Danielsson A, Eckman CB, et al. The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nat Neurosci 2001;4:887–893.PubMedCrossRefGoogle Scholar
  237. 236.
    Wang Z, Natte R, Berliner JA, van Duinen SG, Vinters HV. Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 2000;31:534–538.PubMedGoogle Scholar
  238. 237.
    Levy E, Sastre M, Kumar A, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 2001;60:94–104.PubMedGoogle Scholar
  239. 238.
    Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001;50:765–772.PubMedCrossRefGoogle Scholar
  240. 239.
    Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996;148:351–354.PubMedGoogle Scholar
  241. 240.
    Blevins G, Macaulay R, Harder S, et al. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003;60:1625–1630.PubMedCrossRefGoogle Scholar
  242. 241.
    Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990;136:1223–1228.PubMedGoogle Scholar
  243. 242.
    Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol 1999;45:305–311.PubMedCrossRefGoogle Scholar
  244. 243.
    Mayer M, Straube A, Bruening R, et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol 1999;246:526–532.PubMedCrossRefGoogle Scholar
  245. 244.
    Yousry TA, Seelos K, Mayer M, et al. Characteristic MR lesion pattern and correlation of Tl and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 1999;20:91–100.PubMedGoogle Scholar
  246. 245.
    Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999;399:776–781.PubMedCrossRefGoogle Scholar
  247. 246.
    Vidal R, Revesz T, Rostagno A, et al. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 2000;97:4920–1925.PubMedCrossRefGoogle Scholar
  248. 247.
    Holton JL, Lashley T, Ghiso J, et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 2002;61:254–267.PubMedGoogle Scholar
  249. 248.
    Tohgi H, Abe T, Kimura M, Saheki M, Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 1996;103:1211–1220.PubMedCrossRefGoogle Scholar
  250. 249.
    Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology 2003;60.Google Scholar
  251. 250.
    Oldfors A, Fyhr IM, Holme E, Larsson NG, Tulinius M. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol (Berl) 1990;80:541–546.CrossRefGoogle Scholar
  252. 251.
    Powers JM, DeVivo DC. Peroxismal and mitochondrial disorders. In: Graham D, Lantos P, eds. Greenfield’s Neuropathology. 7th Ed. London, UK: Arnold Publishing, 2002, pp. 737–797.Google Scholar
  253. 252.
    Muller-Hocker J, Hubner G, Bise K, et al. Generalized mitochondrial microangiopathy and vascular cytochrome c oxidase deficiency. Occurrence in a case of MELAS syndrome with mitochondrial cardiomyopathy-myopathy and combined complex I/IV deficiency. Arch Pathol Lab Med 1993;117:202–210.PubMedGoogle Scholar
  254. 253.
    Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1–10.PubMedCrossRefGoogle Scholar
  255. 254.
    Ohama E, O’Hara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (Berl) 1987;74:226–233.CrossRefGoogle Scholar
  256. 255.
    Love S, Hilton DA. Assessment of the distribution of mitochondrial ribosomal RNA in melas and in thrombotic cerebral infarcts by in situ hybridization. J Pathol 1996;178:182–189.PubMedCrossRefGoogle Scholar
  257. 256.
    Bowler J, Hachinski V. Vascular dementia. In: Ginsberg M, Bogousslavsky J, eds. Cerebrovascular disease. II: Patho-physiology, Diagnosis and Management. Oxford, UK: Blackwell Science, 1998, pp. 1126–1144.Google Scholar
  258. 257.
    Kaye JA. Diagnostic challenges in dementia. Neurology 1998;51:S45–S52; discussion S65–7.PubMedGoogle Scholar
  259. 258.
    Mendez MF, Mastri AR, Sung JH, Frey WH. Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord 1992;6:35–43.PubMedCrossRefGoogle Scholar
  260. 259.
    Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet 1999;354:919–920.PubMedCrossRefGoogle Scholar
  261. 260.
    Katzman R, Brown T, Thai LJ, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer’s disease. Ann Neurol 1988;24:384–389.PubMedCrossRefGoogle Scholar
  262. 261.
    Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thai LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 2000;57:1474–1479.PubMedCrossRefGoogle Scholar
  263. 262.
    O’Brien KD, Olin KL, Alpers CE, et al. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998;98:519–527.PubMedGoogle Scholar
  264. 263.
    Cohen CI, Araujo L, Guerrier R, Henry KA. “Mixed dementia”: adequate or antiquated? A critical review. Am J Geriatr Psychiatry 1997;5:279–283.PubMedCrossRefGoogle Scholar
  265. 264.
    Rockwood K. Lessons from mixed dementia. Int Psychogeriatr 1997;9:245–249.PubMedCrossRefGoogle Scholar
  266. 265.
    O’Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988;45:797–798.PubMedGoogle Scholar
  267. 266.
    Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer disease: a postmortem study. Acta Neuropathol 2003;105:14–17.PubMedGoogle Scholar
  268. 267.
    Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer Disease. J Neuropathol Exp Neurol 1997;56:165–170.PubMedGoogle Scholar
  269. 268.
    Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), Part X: Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 1995;45:461–466.PubMedGoogle Scholar
  270. 269.
    Crystal H, Dickson D. Cerebral infarcts in patients with autopsy proven Alzheimer’s disease (abstract). Neurobiol Aging 2002;23:207.Google Scholar
  271. 270.
    Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer’s disease: a postmortem study. Acta Neuropathol (Berl) 2003;105:14–17.Google Scholar
  272. 271.
    Fayet G, Hauw JJ, Delaere P, et al. Neuropathology of 20 centenarians. I: Clinical data. Rev Neurol 1994;150:16–21.PubMedGoogle Scholar
  273. 272.
    Giannakopoulos P, Hof PR, Surini M, Michel JP, Bouras C. Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol 1993;85:602–610.PubMedCrossRefGoogle Scholar
  274. 273.
    Mizutani T, Shimada H. Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 1992;108:168–177.PubMedCrossRefGoogle Scholar
  275. 274.
    Aliev G, Smith MA, Seyidov D, et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer’s disease. Brain Pathol 2002;12:21–35.PubMedCrossRefGoogle Scholar
  276. 275.
    De La Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152–1162.PubMedCrossRefGoogle Scholar
  277. 276.
    Grammas P, Moore P, Weigel PH. Microvessels from Alzheimer’s disease brains kill neurons in vitro. Am J Pathol 1999;154:337–342.PubMedGoogle Scholar
  278. 277.
    Sparks DL. Coronary artery disease: hypertension, ApoE, and cholesterol: a link to Alzheimer’s disease? Ann NY Acad Sci 1997;826:128–146.PubMedCrossRefGoogle Scholar
  279. 278.
    Sparks DL, Hunsaker JC, 3rd, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR. Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease. Neurobiol Aging 1990;11:601–607.PubMedCrossRefGoogle Scholar
  280. 279.
    Kovari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410–414.PubMedCrossRefGoogle Scholar
  281. 280.
    Corbett A, Bennett H, Kos S. Cognitive dysfunction following subcortical infarction. Arch Neurol 1994;51:999–1007.PubMedGoogle Scholar
  282. 281.
    Heyman A, Fillenbaum G, Welsh-Bohmer K, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease, CERAD, Part XVIII (abstract). Neurology 1998,51:159–162.PubMedGoogle Scholar
  283. 282.
    Frisoni GB, Geroldi C. Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease. Arch Neurol 2001;58:1939–1940.PubMedCrossRefGoogle Scholar
  284. 283.
    Brun A. Neuropathology of cerebrovascular lesions in dementia. Seventh International Conference on Alzheimer’s Disease and Related Disorders. Neurobiol Aging 2000;21:S7.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • Kurt A. Jellinger
    • 1
  1. 1.Institute of Clinical Neurobiology and University of ViennaViennaAustria

Personalised recommendations